Cargando…

Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials

Since December 2019, COVID-19 has spread across the world almost through 2.5 years. As of 16 June 2022, the cumulative number of confirmed cases of COVID-19 worldwide has reached 542.62 million, and the death toll has risen to 6.33 million. With the increasing number of deaths, it is urgent to find...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhenchao, Han, Zhifei, Liu, Beibei, Shen, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493488/ https://www.ncbi.nlm.nih.gov/pubmed/36160434 http://dx.doi.org/10.3389/fphar.2022.971890

Ejemplares similares

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022)

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
por: Sisay, Mekonnen
Publicado: (2020)

Evaluation of safety and effectiveness of remdesivir in treating COVID-19 patients after emergency use authorization study
por: Burhan, Erlina, et al.
Publicado: (2023)

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2023)

Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study
por: Yao, Taikang, et al.
Publicado: (2023)

Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
por: Mohiuddin Chowdhury, Abu Taiub Mohammed, et al.
Publicado: (2022)

Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS
por: Wu, Bin, et al.
Publicado: (2022)

Remdesivir associated sinus bradycardia in patients with COVID-19: A prospective longitudinal study
por: Hajimoradi, Maryam, et al.
Publicado: (2023)

Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys
por: Xu, Lin, et al.
Publicado: (2021)

Is Ivermectin Effective in Treating COVID-19?
por: Yang, Shuangshuang, et al.
Publicado: (2022)

A retrospective real-world study of early short-course remdesivir in non-hospitalized COVID-19 patients at high risk for progression: low rate of hospitalization or death, regardless of immunocompetence status
por: Ramos-Rincón, José Manuel, et al.
Publicado: (2023)

Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2021)

Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir
por: Du, Ping, et al.
Publicado: (2022)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
por: Yu, Mi, et al.
Publicado: (2022)

Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care
por: Rivera, Christina G., et al.
Publicado: (2023)

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
por: Hsu, Hsing-Yu, et al.
Publicado: (2021)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

COVID-19-ASSOCIATED MENINGOENCEPHALITIS TREATED WITH STEROIDS AND REMDESIVIR
por: AZAZ CHEEMA, MUHAMMAD, et al.
Publicado: (2021)

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)

73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir
por: Diaz, George, et al.
Publicado: (2020)

Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis
por: Shih, Weichung J., et al.
Publicado: (2020)

In vitro effect of Withania somnifera, AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb−drug interactions in the management of COVID-19
por: Kasarla, Siva Swapna, et al.
Publicado: (2022)

Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
por: Li, Yan, et al.
Publicado: (2021)

A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir
por: Zheng, Jiantao, et al.
Publicado: (2023)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

Remdesivir for patients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

The use of remdesivir outside of clinical trials during the COVID-19 pandemic
por: Halimi, Vesa, et al.
Publicado: (2020)

Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone
por: Wong, Carlos K. H., et al.
Publicado: (2022)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023)

Liver and kidney function in patients with Covid‐19 treated with remdesivir
por: van Laar, Sylvia A., et al.
Publicado: (2021)

Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir
por: Wongboonsin, Janewit, et al.
Publicado: (2021)

Severe COVID-19 Pneumonia in an Unvaccinated Female Treated With Remdesivir
por: Ortega, Kaylee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6kdvjrka5cqecf5cbt80diakv4